Theriva Biologics (FRA:SFY0) FFO


FRA:SFY0 Theriva Biologics Inc FRA:SFY0
24 GF Score
Price €2.42
! 3 Warning Signs
View Full Analysis

What is Theriva Biologics FFO?

FFO (Funds from operations) only applies to REITs.

FRA:SFY0
24GF Score
Theriva Biologics Inc FRA:SFY0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Theriva Biologics Business Description

Other Exchanges TOVX:USA
Address 9605 Medical Center Drive, Suite 270, Rockville, MD, USA, 20850
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
24GF Score

Get the complete analysis for FRA:SFY0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.42
Price